What's in Protein Sciences Corporation's pipeline?

Protein Sciences Corporation has 7 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Protein Sciences Corporation's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Sanofi Pasteur, a Sanofi Company, Institut National de la Santé Et de la Recherche Médicale, France, MedImmune LLC, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/protein-sciences-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Protein Sciences Corporation — Portfolio Competitive Intelligence Brief

Protein Sciences Corporation pipeline: 0 marketed, 0 filed, 4 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
FluBlok Influenza Vaccination	FluBlok Influenza Vaccination	phase 3	Recombinant protein vaccine	Influenza hemagglutinin (HA)	Immunology / Infectious Disease
Flublok® Quadrivalent Influenza Virus Vaccine	Flublok® Quadrivalent Influenza Virus Vaccine	phase 3	Influenza vaccine	Influenza hemagglutinin (HA) antigen	Immunology / Infectious Disease
Flublok Quadrivalent Influenza Vaccine	Flublok Quadrivalent Influenza Vaccine	phase 3	Recombinant protein vaccine	Influenza hemagglutinin (HA) antigen	Immunology / Infectious Disease
Fluarix Quadrivalent® Influenza Virus Vaccine	Fluarix Quadrivalent® Influenza Virus Vaccine	phase 3	Inactivated influenza vaccine		Immunology

Therapeutic area mix

Immunology / Infectious Disease · 3
Immunology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 3 shared drug classes
Sanofi Pasteur, a Sanofi Company · 2 shared drug classes
Institut National de la Santé Et de la Recherche Médicale, France · 2 shared drug classes
MedImmune LLC · 2 shared drug classes
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · 2 shared drug classes
Novartis · 2 shared drug classes
ModernaTX, Inc. · 2 shared drug classes
Seqirus · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Protein Sciences Corporation:

Cite this brief

Drug Landscape (2026). Protein Sciences Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/protein-sciences-corporation. Accessed 2026-05-14.